BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21217774)

  • 1. RAC3 is a pro-migratory co-activator of ERα.
    Walker MP; Zhang M; Le TP; Wu P; Lainé M; Greene GL
    Oncogene; 2011 Apr; 30(17):1984-94. PubMed ID: 21217774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rac1 and Rac3 isoform activation is involved in the invasive and metastatic phenotype of human breast cancer cells.
    Baugher PJ; Krishnamoorthy L; Price JE; Dharmawardhane SF
    Breast Cancer Res; 2005; 7(6):R965-74. PubMed ID: 16280046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A transcriptional repressive role for epithelial-specific ETS factor ELF3 on oestrogen receptor alpha in breast cancer cells.
    Gajulapalli VN; Samanthapudi VS; Pulaganti M; Khumukcham SS; Malisetty VL; Guruprasad L; Chitta SK; Manavathi B
    Biochem J; 2016 Apr; 473(8):1047-61. PubMed ID: 26920025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
    Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
    BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unveiling the role of RAC3 in the growth and invasion of cisplatin-resistant bladder cancer cells.
    Li H; Ma H; Ma J; Qin F; Fan S; Kong S; Zhao S; Ma J
    J Cell Mol Med; 2024 Jun; 28(11):e18473. PubMed ID: 38847477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dependence receptor UNC5A restricts luminal to basal breast cancer plasticity and metastasis.
    Padua MB; Bhat-Nakshatri P; Anjanappa M; Prasad MS; Hao Y; Rao X; Liu S; Wan J; Liu Y; McElyea K; Jacobsen M; Sandusky G; Althouse S; Perkins S; Nakshatri H
    Breast Cancer Res; 2018 May; 20(1):35. PubMed ID: 29720215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rac3 regulates breast cancer invasion and metastasis by controlling adhesion and matrix degradation.
    Donnelly SK; Cabrera R; Mao SPH; Christin JR; Wu B; Guo W; Bravo-Cordero JJ; Condeelis JS; Segall JE; Hodgson L
    J Cell Biol; 2017 Dec; 216(12):4331-4349. PubMed ID: 29061650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Estrogen Receptor Cofactor SPEN Functions as a Tumor Suppressor and Candidate Biomarker of Drug Responsiveness in Hormone-Dependent Breast Cancers.
    Légaré S; Cavallone L; Mamo A; Chabot C; Sirois I; Magliocco A; Klimowicz A; Tonin PN; Buchanan M; Keilty D; Hassan S; Laperrière D; Mader S; Aleynikova O; Basik M
    Cancer Res; 2015 Oct; 75(20):4351-63. PubMed ID: 26297734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPEN, a new player in primary cilia formation and cell migration in breast cancer.
    Légaré S; Chabot C; Basik M
    Breast Cancer Res; 2017 Sep; 19(1):104. PubMed ID: 28877752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the Rho GTPase, Rac1, decreases estrogen receptor levels and is a novel therapeutic strategy in breast cancer.
    Rosenblatt AE; Garcia MI; Lyons L; Xie Y; Maiorino C; Désiré L; Slingerland J; Burnstein KL
    Endocr Relat Cancer; 2011 Apr; 18(2):207-19. PubMed ID: 21118977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
    Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
    Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor-dependent regulation of CYP2B6 in human breast cancer cells.
    Lo R; Burgoon L; Macpherson L; Ahmed S; Matthews J
    Biochim Biophys Acta; 2010; 1799(5-6):469-79. PubMed ID: 20079471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The small GTPase RAC3 gene is located within chromosome band 17q25.3 outside and telomeric of a region commonly deleted in breast and ovarian tumours.
    Morris CM; Haataja L; McDonald M; Gough S; Markie D; Groffen J; Heisterkamp N
    Cytogenet Cell Genet; 2000; 89(1-2):18-23. PubMed ID: 10894930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERalpha as ligand-independent activator of CDH-1 regulates determination and maintenance of epithelial morphology in breast cancer cells.
    Cardamone MD; Bardella C; Gutierrez A; Di Croce L; Rosenfeld MG; Di Renzo MF; De Bortoli M
    Proc Natl Acad Sci U S A; 2009 May; 106(18):7420-5. PubMed ID: 19383788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation.
    Konduri SD; Medisetty R; Liu W; Kaipparettu BA; Srivastava P; Brauch H; Fritz P; Swetzig WM; Gardner AE; Khan SA; Das GM
    Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15081-6. PubMed ID: 20696891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer.
    Lu W; Katzenellenbogen BS
    Horm Cancer; 2017 Aug; 8(4):230-242. PubMed ID: 28577282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-497 downregulation contributes to cell proliferation, migration, and invasion of estrogen receptor alpha negative breast cancer by targeting estrogen-related receptor alpha.
    Han L; Liu B; Jiang L; Liu J; Han S
    Tumour Biol; 2016 Oct; 37(10):13205-13214. PubMed ID: 27456360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver kinase B1 expression (LKB1) is repressed by estrogen receptor alpha (ERα) in MCF-7 human breast cancer cells.
    Linher-Melville K; Zantinge S; Singh G
    Biochem Biophys Res Commun; 2012 Jan; 417(3):1063-8. PubMed ID: 22226967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis.
    Sayeed A; Konduri SD; Liu W; Bansal S; Li F; Das GM
    Cancer Res; 2007 Aug; 67(16):7746-55. PubMed ID: 17699779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
    Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
    Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.